Navigation Links
Shionogi Announces FDA Approval of KAPVAY™ - The First and Only Therapy Approved for Use with Stimulant Medication for the Treatment of ADHD
Date:10/4/2010

FLORHAM PARK, N.J., Oct. 4 /PRNewswire/ -- Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., today announced the U.S. Food and Drug Administration approval of the non-stimulant medication KAPVAY™ (clonidine hydrochloride) extended-release tablets, an extended-release oral formulation for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents ages 6-17 years. KAPVAY™ is the only formulation of clonidine hydrochloride approved by the FDA for the treatment of ADHD, and is the first and only FDA-approved ADHD treatment indicated for use as add-on therapy to stimulant medication. KAPVAY™ can also be used as monotherapy when treating ADHD.

An oral, non-stimulant, twice-daily therapy, KAPVAY™ is a centrally acting alpha2-adrenergic receptor agonist. While the mechanism of action of alpha2 agonists in ADHD is not known, it is believed to involve the pre-frontal cortex (PFC) of the brain. Studies suggest that the PFC regulates attention and plays a critical role in impulse control, working memory and executive function.

"The FDA approval of KAPVAY™ represents an exciting milestone in the field of ADHD," said Donald C. Manning, MD, PhD, Chief Medical Officer of Shionogi Inc. "The extended-release formulation of KAPVAY™ minimizes the peaks and troughs in blood levels, thereby decreasing overactivation of the alpha receptors in the brain and periphery. We look forward to providing this important, beneficial treatment for ADHD to patients, both as monotherapy and add-on therapy to stimulants."

"ADHD is a complex disorder that requires individualized treatment. While there are prescription treatment options available, many ADHD patients on stimulants do not achieve adequate control of symptoms," explained Rakesh Jain, MD, MPH, Director of Psychiatric Drug Research for R/D Clinical Research at Lake Jackson, Texas, and an investigator in the clinical trials. "KAP
'/>"/>

SOURCE Shionogi Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Stallergenes and Shionogi Sign Exclusive Partnership Agreements for Immunotherapy Tablets in Japan
2. BioCrysts Partner Shionogi Receives Marketing & Manufacturing Approval For Peramivir in Japan
3. Orexigen® Therapeutics Announces Upcoming Data Presentations at the 28th Annual Scientific Meeting of The Obesity Society
4. Intra-Cellular Therapies Announces Positive Results with ITI-002 in Pre-Clinical Models of Parkinsons Disease
5. Bioheart, Inc. Announces Loan to be Assumed by Seaside
6. Shire Announces Results of the Tender Offer for Movetis NV and Commencement of Squeeze-Out Tender Period
7. IGEN AMENDS DISTRIBUTION AGREEMENT AND ANNOUNCES FIRST SPECTRUM BUILD-OUT
8. Crescendo Biologics Announces First Triple Knockout Mouse
9. Pepscan Therapeutics Announces Establishment of Scientific Advisory Board
10. Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Fourth Quarter Fiscal 2010
11. Cellectis Bioresearch Announces Availability of Research Kits Through New Online E-Store
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... 2015 Dr. Robert Hanzlik, whose groundbreaking ... carries implications for advancing the creation of safer pharmaceuticals, ... National University , the second-largest private, nonprofit university in ... a professor at the University of Kansas School of ... starts at 5 p.m. and takes place at National ...
(Date:4/27/2015)... NORTH BRUNSWICK, New Jersey , ... Pharmaceuticals, société de découverte médicamenteuse spécialisée ... d,agents antibiotiques destinés à soigner les ... annoncé aujourd,hui la présentation de données ... clinique majeur, le TXA709, dans la ...
(Date:4/27/2015)... April 27, 2015 SynGen Inc., a company ... systems that harvest stem and progenitor cells from umbilical ... announced today that it has added three new members ... Cord Blood Business Units focus on product commercialization. ... as its Vice President and Chief Financial Officer.  Chuck ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 DryLet, ... use in applications such as animal waste reduction, ... oil reduction in wastewater treatment plants and restaurant ... exhibitor at the Texas Commission on Environmental Quality ... in Austin, Texas. , The company will highlight ...
Breaking Biology Technology:Dr. Robert Hanzlik Discusses Pharmaceutical Testing Models at Event Hosted by National University 2Dr. Robert Hanzlik Discusses Pharmaceutical Testing Models at Event Hosted by National University 3TAXIS Pharmaceuticals démontre la puissance clinique du TXA709 dans la lutte contre la résistance aux antibiotiques 2TAXIS Pharmaceuticals démontre la puissance clinique du TXA709 dans la lutte contre la résistance aux antibiotiques 3TAXIS Pharmaceuticals démontre la puissance clinique du TXA709 dans la lutte contre la résistance aux antibiotiques 4TAXIS Pharmaceuticals démontre la puissance clinique du TXA709 dans la lutte contre la résistance aux antibiotiques 5TAXIS Pharmaceuticals démontre la puissance clinique du TXA709 dans la lutte contre la résistance aux antibiotiques 6SynGen Inc. Expands Its Management Team 2DryLet to Showcase Multiple Products at Texas Commission on Environmental Quality Trade Fair and Conference May 5-6 in Austin, Texas 2
... scare tactics. However, there is one area where I finally decided ... ,Oh sure, there are various articles and such that describe the ... on). The problem is that at least half of us use ... decided to prove my point. I took my laptop home from ...
... of the ways Internet con artists may try to steal ... sites. Be on the alert these fakes may look ... look like they come from major financial institutions or charities. ... Listen to this episode (1.4-megabyte MP3) ...
... popular and profitable AdWords program. AdWords allows advertisers to ... Google searches that use specific words, which can be ... discussed a U.S. District Court decision that allowed Google ... sponsored links from Geico's competitors. I warned that the ...
Cached Biology Technology:Screen-door security: most wireless networks left wide open 2Screen-door security: most wireless networks left wide open 3Internet trademark war goes international 2Internet trademark war goes international 3
(Date:4/17/2015)... Canada , April 17, 2015 ... growing security concerns, and technological advancement to drive ... until 2020   According ... Saudi Arabia Biometric Systems Market Forecast &  Opportunities, 2020 ", biometric systems ... is projected to register growth at CAGR of ...
(Date:4/13/2015)... April 13, 2015  higi, a leading cloud-based consumer ... more fully engage with their communities around health and ... protected and secure API.  ... most accessible, affordable, and convenient vehicle to receive validated ... The API will allow higi,s trusted ...
(Date:4/6/2015)... , Apr. 6, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile ... provisional patent 62/143028 for MINIATURE, MULTI-PURPOSE ... TRANSFER  NXT-ID introduces a new revolutionary ... patent surrounds the use of miniature antenna modules ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4
... WASHINGTON -- The draft 10-year strategic plan for ... shapes and coordinates climate and related global environmental change ... federal government -- is "evolving in the right direction," ... says a new report from the National Research Council. ...
... Institute of Technology and Emory University for delivering ... the eye provides the foundation for a startup ... capital investment., The Atlanta-based startup, Clearside Biomedical, plans ... microneedles to precisely target therapeutics within the eye. ...
... North Atlantic over the last 32 years has significantly reduced ... in sharply higher death rates among seal pups in recent ... "The kind of mortality we,re seeing in eastern Canada is ... in low ice years essentially all of the pups ...
Cached Biology News:New report reviews plan for US Global Change Research Program 2Startup receives $4 million to develop drug delivery targeted to the back of the eye 2Startup receives $4 million to develop drug delivery targeted to the back of the eye 3Harp seals on thin ice after 32 years of warming 2
Recommended for use as a cell culture substratum at 0.1-0.2 mg/cm 2 or 5-10 μl/cm 2 . Optimal concentration depends on cell type as well as the application or research objectives. Type B...
... separation system using the asymmetric flow Field ... easily with Wyatts multi-angle light scattering (MALS) ... the Optilab DSP. The combined system provides ... the particles/molecules separated by the AFFF unit. ...
... reagent kit for determining the absolute count ... samples, mobilized peripheral blood samples, and leukapheresis ... total nucleated cell count and a total ... designed for use in the BD Procount ...
... poorly to Protein A and, until recently, no ... step IgM purification. Standard methods for IgM purification ... not effective for removing all of the major ... Pierce has developed an easy-to-use affinity ...
Biology Products: